Medicine and Dentistry
Neuropathy
95%
Oxaliplatin
89%
Colorectal Carcinoma
69%
Polyneuropathy
63%
Breast Cancer
48%
Docetaxel
46%
Quality of Life
40%
Cancer Therapy
39%
Chemotherapy-Induced Peripheral Neuropathy
37%
Adjuvant Chemotherapy
35%
Observational Study
32%
Excitability
32%
Neuropathic Pain
32%
Chronic Pain
29%
Prospective Study
25%
Cold Allodynia
21%
Paresthesia
18%
Randomized Controlled Trial
17%
Gemcitabine
16%
Paclitaxel
16%
Oxaliplatin-Induced Peripheral Neuropathy
16%
Emotional Well-Being
16%
Sequela
16%
Pancreas Cancer
16%
Nociception
16%
Contralateral
16%
Sodium Channel
16%
Neurotoxicity
14%
Pain Assessment
13%
Nerve Excitability
13%
Nerve Conduction Study
11%
Malignant Neoplasm
9%
Biological Marker
9%
Dysesthesia
8%
Quantitative Sensory Testing
8%
Combination Chemotherapy
8%
Neurological Complication
8%
Numeric Rating Scale
8%
Clinician
8%
Axon
7%
Thermal Hyperalgesia
7%
Late Effect
6%
Sensation
6%
Prevalence
6%
Side Effect
5%
Patient Referral
5%
Pain Catastrophizing
5%
Brief Pain Inventory
5%
Fatigue (Symptom)
5%
Urinary System
5%
Pharmacology, Toxicology and Pharmaceutical Science
Oxaliplatin
89%
Chemotherapy
79%
Docetaxel
63%
Neuropathy
62%
Colorectal Carcinoma
53%
Polyneuropathy
43%
Chemotherapy-Induced Peripheral Neuropathy
37%
Malignant Neoplasm
34%
Paclitaxel
32%
Breast Cancer
32%
Oxaliplatin-Induced Peripheral Neuropathy
25%
Chronic Pain
24%
Cross-Sectional Study
21%
Prospective Study
19%
Oxaliplatin-Induced Neuropathy
18%
Randomized Controlled Trial
17%
Fish Oil
16%
Pancreas Cancer
16%
Gemcitabine
16%
Cold Allodynia
16%
Paresthesia
13%
Dysesthesia
8%
Prevalence
7%
Neurotoxicity
6%
Biological Marker
6%
Sensory Neuropathy
5%
Neuroscience
Oxaliplatin
100%
Neuropathy
97%
Docetaxel
62%
Polyneuropathy
43%
Axonal Excitability
32%
Neuropathic Pain
28%
Axon
25%
Quantitative Sensory Testing
22%
Excitability
20%
Nerve Excitability
18%
In Vivo
17%
Sodium Channel
16%
Paclitaxel
16%
Neurofilament Light Chain
16%
In Vitro
16%
Hyperalgesia
12%
Nerve Conduction Study
11%
Allodynia
10%
Neurotoxicity
8%
Catastrophizing
8%
